Preliminary research reveal conolidine may perhaps inhibit unique ion channels, decreasing neuronal excitability and limiting agony signals. This mechanism is particularly applicable in neuropathic soreness, in which irregular signaling results in persistent distress. Furthermore, conolidine seems to affect G protein-coupled receptor (GPCR) pathway